BAY 1135626, CAS [[1404071-37-9]]

Artikelnummer: MCE-HY-147281
Artikelname: BAY 1135626, CAS [[1404071-37-9]]
Artikelnummer: MCE-HY-147281
Hersteller Artikelnummer: HY-147281
Alternativnummer: MCE-HY-147281-100MG,MCE-HY-147281-5MG,MCE-HY-147281-1MG,MCE-HY-147281-50MG,MCE-HY-147281-10MMX1ML,MCE-HY-147281-25MG,MCE-HY-147281-10MG
Hersteller: MedchemExpress
Kategorie: Biochemikalien
BAY 1135626 is used to synthesize BAY 1129980, and use to anti-tumor research. BAY 1129980 is a Auristatin-based anti-C4.4A (LYPD3) antibody-agent conjugate (ADC), is used to non-small cell lung cancer (NSCLC) research[1].
Molekulargewicht: 1063.33
Reinheit: 99.19
CAS Nummer: [1404071-37-9]
Formel: C55H86N10O11
Target-Kategorie: Drug-Linker Conjugates for ADC
Anwendungsbeschreibung: MCE Product type: ADC Related